ADIPOQ and diabetic kidney disease: Previous studies have shown that in diabetic nephropathy (DN) patients, serum adiponectin levels are notably lower than those of non-DN patients; in diabetic retinopathy (DR) patients, serum adiponectin levels are notably higher compared with non-DR patients (8).